BioTek Instruments Named ‘Vermont Business Growth Award’ Winner
News Aug 01, 2017
BioTek Instruments will be recognized as a 2017 Vermont Business Growth Award winner at a ceremony to be held September 12, 2017 at The Sheraton Hotel & Conference Center, in Burlington, VT. This award is sponsored by Vermont Business Magazine and KeyBank, and is presented to the five Vermont businesses that have experienced the greatest growth over the past five years in various business categories.
BioTek will be recognized as one of the winners in the Technology category for the company’s 28.3% growth over the past five years. This is the sixth time that the company has received this award.
“This award has particular meaning for us this year as we look forward to celebrating the company’s 50th anniversary,” commented BioTek’s President and CEO, Briar Alpert. “We are proud to continue to keep our headquarters, manufacturing, research and development, applications and service right here in Vermont and look forward to the years of growth ahead of us.”
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. BioTek espouses a "Think Possible" approach that sets the tone for fresh ideas, unsurpassed customer service and original innovations.
T Cells Attack and Kill Dopamine-Producing Cells in Parkinson's diseaseNews
Researchers in Germany discover a potential new target for treating Parkinson's diseaseREAD MORE
Kidney Cancer Driver Could Lead to New Treatment StrategyNews
Scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change. Scientists have known this genetic change can lead to an overabundance of blood vessels, which help feed nutrients to the tumors. Their latest finding shows a potential new cancer-driving pathway.READ MORE
Targeting Headaches and Tumors with Nano-SubmarinesNews
Scientists have developed a new method to enable miniature drug-filled nanocarriers to dock on to immune cells, which in turn attack tumors. In the future, this may lead to targeted treatment that can largely eliminate damage to healthy tissue.READ MORE